Bowel obstructions can make you feel sick
This will be explained in more detail during the initial phone consultation prior to the in-person appointment
Morovatdar N, Poorzand H, Bondarsahebi Y, Hozhabrossadati SA, Montazeri S, Sahebkar A
Y, al menos, una enfermedad asociada al exceso de peso
Key points highlighted in the session included: GLP-1 receptor agonists have been used clinically since 2005, with earlier formulations prescribed at lower doses Newer medications and dosing regimens have increased weight loss outcomes Public familiarity with medications such as Ozempic, Wegovy, Mounjaro, and Zepbound has grown rapidly Increased access and demand have led to broader prescribing patterns and new clinical questions This growth has outpaced many clinicians training around eating disorder risk and weight-inclusive care